NO990814L - Chemical connections - Google Patents

Chemical connections

Info

Publication number
NO990814L
NO990814L NO990814A NO990814A NO990814L NO 990814 L NO990814 L NO 990814L NO 990814 A NO990814 A NO 990814A NO 990814 A NO990814 A NO 990814A NO 990814 L NO990814 L NO 990814L
Authority
NO
Norway
Prior art keywords
chemical connections
connections
chemical
Prior art date
Application number
NO990814A
Other languages
Norwegian (no)
Other versions
NO309305B1 (en
NO990814D0 (en
Inventor
Bernt Boerretzen
Vidar Moen
Rolf Olaf Larsen
Erik Olai Pettersen
Camilla Bruno Dunsaed
Geir Sagvolden
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO990814A priority Critical patent/NO309305B1/en
Publication of NO990814D0 publication Critical patent/NO990814D0/en
Priority to CA002363670A priority patent/CA2363670A1/en
Priority to PCT/NO2000/000060 priority patent/WO2000048610A1/en
Priority to SK1161-2001A priority patent/SK11612001A3/en
Priority to HU0105281A priority patent/HUP0105281A2/en
Priority to JP2000599400A priority patent/JP2002537263A/en
Priority to AU28342/00A priority patent/AU2834200A/en
Priority to IL14489600A priority patent/IL144896A0/en
Priority to HU0105280A priority patent/HUP0105280A2/en
Priority to RU2001123035/14A priority patent/RU2001123035A/en
Priority to CN00806338A priority patent/CN1347322A/en
Priority to MXPA01008346A priority patent/MXPA01008346A/en
Priority to MXPA01008347A priority patent/MXPA01008347A/en
Priority to PCT/NO2000/000059 priority patent/WO2000048609A1/en
Priority to CZ20012966A priority patent/CZ20012966A3/en
Priority to EP00906782A priority patent/EP1150690A1/en
Priority to JP2000599401A priority patent/JP2002537264A/en
Priority to BR0008297-0A priority patent/BR0008297A/en
Priority to CZ20012965A priority patent/CZ20012965A3/en
Priority to IL14489500A priority patent/IL144895A0/en
Priority to CN00806488A priority patent/CN1347323A/en
Priority to CA002362306A priority patent/CA2362306A1/en
Priority to BR0008302-0A priority patent/BR0008302A/en
Priority to PL00350519A priority patent/PL350519A1/en
Priority to AU28341/00A priority patent/AU2834100A/en
Priority to RU2001123124/15A priority patent/RU2001123124A/en
Priority to EP00906781A priority patent/EP1150689A1/en
Priority to PL00350520A priority patent/PL350520A1/en
Priority to SK1160-2001A priority patent/SK11602001A3/en
Publication of NO990814L publication Critical patent/NO990814L/en
Publication of NO309305B1 publication Critical patent/NO309305B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
NO990814A 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives NO309305B1 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives
SK1160-2001A SK11602001A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives useful as anticancer agents
CZ20012966A CZ20012966A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives that are suitable for use as antitumor preparations
JP2000599401A JP2002537264A (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives
PCT/NO2000/000060 WO2000048610A1 (en) 1999-02-19 2000-02-18 Chemical compounds
HU0105281A HUP0105281A2 (en) 1999-02-19 2000-02-18 Anticancer benzaldehyde derivatives and their pharmaceutical use
JP2000599400A JP2002537263A (en) 1999-02-19 2000-02-18 Chemical substances
AU28342/00A AU2834200A (en) 1999-02-19 2000-02-18 Chemical compounds
IL14489600A IL144896A0 (en) 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds
HU0105280A HUP0105280A2 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives and their pharmaceutical use and medicaments containing the compounds
RU2001123035/14A RU2001123035A (en) 1999-02-19 2000-02-18 CHEMICAL COMPOUNDS
CN00806338A CN1347322A (en) 1999-02-19 2000-02-18 Chemical compounds
MXPA01008346A MXPA01008346A (en) 1999-02-19 2000-02-18 Chemical compounds.
MXPA01008347A MXPA01008347A (en) 1999-02-19 2000-02-18 Chemical compounds.
PCT/NO2000/000059 WO2000048609A1 (en) 1999-02-19 2000-02-18 Chemical compounds
CA002363670A CA2363670A1 (en) 1999-02-19 2000-02-18 Chemical compounds
EP00906782A EP1150690A1 (en) 1999-02-19 2000-02-18 Chemical compounds
SK1161-2001A SK11612001A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives useful as anticancer agents
BR0008297-0A BR0008297A (en) 1999-02-19 2000-02-18 Use of 4,6-o- (benzylidene-d1) -d-glucopyranose, 4,6-o-benzylidene-1-glucopyranose, and / or 4,6-o- (benzylidene-d1) -l-glucopyranose, or an acceptable pharmaceutical salt thereof, derived from benzaldehyde pharmaceutical composition, and process for the manufacture thereof
CZ20012965A CZ20012965A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives that are suitable for use as antitumor preparations
IL14489500A IL144895A0 (en) 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds
CN00806488A CN1347323A (en) 1999-02-19 2000-02-18 Chemical compounds
CA002362306A CA2362306A1 (en) 1999-02-19 2000-02-18 Chemical compounds
BR0008302-0A BR0008302A (en) 1999-02-19 2000-02-18 Use of a benzaldehyde derivative, benzaldehyde derivative, pharmaceutical composition, and process for manufacturing it
PL00350519A PL350519A1 (en) 1999-02-19 2000-02-18 Chemical compounds
AU28341/00A AU2834100A (en) 1999-02-19 2000-02-18 Chemical compounds
RU2001123124/15A RU2001123124A (en) 1999-02-19 2000-02-18 Chemical compounds
EP00906781A EP1150689A1 (en) 1999-02-19 2000-02-18 Chemical compounds
PL00350520A PL350520A1 (en) 1999-02-19 2000-02-18 Chemical compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives

Publications (3)

Publication Number Publication Date
NO990814D0 NO990814D0 (en) 1999-02-19
NO990814L true NO990814L (en) 2000-08-21
NO309305B1 NO309305B1 (en) 2001-01-15

Family

ID=19902986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives

Country Status (15)

Country Link
EP (2) EP1150689A1 (en)
JP (2) JP2002537264A (en)
CN (2) CN1347323A (en)
AU (2) AU2834200A (en)
BR (2) BR0008302A (en)
CA (2) CA2362306A1 (en)
CZ (2) CZ20012965A3 (en)
HU (2) HUP0105280A2 (en)
IL (2) IL144895A0 (en)
MX (2) MXPA01008346A (en)
NO (1) NO309305B1 (en)
PL (2) PL350520A1 (en)
RU (2) RU2001123124A (en)
SK (2) SK11612001A3 (en)
WO (2) WO2000048609A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4182218B2 (en) * 2001-05-30 2008-11-19 学校法人東京理科大学 Novel glucose derivative that induces apoptosis, process for its production and its use as a medicament
DE10261807A1 (en) 2002-12-19 2004-07-01 Turicum Drug Development Ag Deuterated catecholamine derivatives and medicinal products containing these compounds
AR054583A1 (en) * 2005-07-26 2007-06-27 Altana Pharma Ag PANTOPRAZOL ISOTOPICALLY REPLACED
EA016814B1 (en) * 2005-07-26 2012-07-30 Никомед Гмбх Isotopically substituted proton pump inhibitors
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
CN101157711B (en) * 2007-09-28 2010-12-08 西安交通大学 Compound having antineoplastic activity and uses thereof
RU2010144744A (en) * 2008-04-03 2012-05-10 Когнейт 3, Ллс (Us) COMPOSITIONS AND METHODS OF IMMUNOTHERAPY
CN101735284B (en) * 2008-11-24 2012-05-23 上海医药工业研究院 Method for preparing 4, 6-O-benzylidene-D-glucopyranose
KR102372145B1 (en) 2013-12-03 2022-03-07 인트라-셀룰라 써래피스, 인코퍼레이티드. Novel methods
SI3125893T1 (en) * 2014-04-04 2023-12-29 Intra-Cellular Therapies, Inc. Deuterated heterocycle fused gamma-carbolines as antagonists of 5-ht2a receptors
JP6898072B2 (en) * 2015-08-27 2021-07-07 秀行 佐谷 14-3-3 Protein activity regulator
CA3016353C (en) 2016-03-25 2021-04-27 Intra-Cellular Therapies, Inc. Deuterated fused heterocycle gamma-carbolines and compositions thereof useful in the treatment of nervous system disorders
EP3525763A4 (en) 2016-10-12 2020-06-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
KR20220066988A (en) 2017-03-24 2022-05-24 인트라-셀룰라 써래피스, 인코퍼레이티드. Novel compositions and methods
AU2019331490A1 (en) 2018-08-31 2021-03-18 Intra-Cellular Therapies, Inc. Novel methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB811510A (en) * 1954-12-20 1959-04-08 Gyogyszeripari Ki New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof
JPS6112623A (en) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd Encephalinase inhibiting agent
JPS6256423A (en) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd Remedy and ameliorating agent for cachexia
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
JPH07145191A (en) * 1993-11-24 1995-06-06 Japan Tobacco Inc Galactosyl phosphonate derivative

Also Published As

Publication number Publication date
PL350519A1 (en) 2002-12-16
AU2834200A (en) 2000-09-04
BR0008302A (en) 2002-08-27
IL144895A0 (en) 2002-06-30
IL144896A0 (en) 2002-06-30
MXPA01008346A (en) 2003-06-06
CN1347323A (en) 2002-05-01
EP1150690A1 (en) 2001-11-07
WO2000048609A1 (en) 2000-08-24
EP1150689A1 (en) 2001-11-07
CA2363670A1 (en) 2000-08-24
RU2001123035A (en) 2004-03-20
BR0008297A (en) 2002-05-28
SK11602001A3 (en) 2002-02-05
SK11612001A3 (en) 2002-04-04
CZ20012965A3 (en) 2002-03-13
JP2002537263A (en) 2002-11-05
HUP0105280A2 (en) 2002-04-29
CZ20012966A3 (en) 2002-03-13
AU2834100A (en) 2000-09-04
JP2002537264A (en) 2002-11-05
NO309305B1 (en) 2001-01-15
WO2000048610A1 (en) 2000-08-24
HUP0105281A2 (en) 2002-05-29
CA2362306A1 (en) 2000-08-24
CN1347322A (en) 2002-05-01
NO990814D0 (en) 1999-02-19
MXPA01008347A (en) 2004-03-10
RU2001123124A (en) 2004-02-20
PL350520A1 (en) 2002-12-16

Similar Documents

Publication Publication Date Title
NO20020765D0 (en) Chemical connections
NO20021637D0 (en) Chemical connections
NO20006152L (en) Chemical connections
NO20024774D0 (en) Chemical connections
NO20032829L (en) Chemical connections
NO20031561D0 (en) Chemical connections
NO2010019I2 (en) 6-per-deoxy-6-per- (2-karboksetyl) thio-y-cyclodextrin
NO20002359D0 (en) Chemical connections
NO20002360D0 (en) Chemical connections
NO20002361D0 (en) Chemical connections
ATA51899A (en) handstamp
ATE357433T1 (en) 4-PYRIMIDINYL-N-ACYL-L-PHENYLANINE
FI4231U1 (en) CASE
NO20030628D0 (en) Chemical connections
ATE297895T1 (en) 4-PYRIDINYL-N-ACYL-L-PHENYLALANINE
NO990814L (en) Chemical connections
DE60024400D1 (en) receiving set
NO20021815D0 (en) Connection
ATE269311T1 (en) BENZOYLPYRIDAZINE
ATA121799A (en) AUSBEULGERÄT
NO993313D0 (en) Chemical connections
ATE440824T1 (en) NITRO-SULFOBENSAMIDE
ATA107599A (en) HEIZWASSERBEREITER
DE29907427U1 (en) case
NO20001448D0 (en) Chemical connections

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2003